PIM
ROIV icon

Platinum Investment Management’s Roivant Sciences ROIV Stock Holding History

Platinum Investment Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.27M Hold
92,397
– – 0.8% 48
2026
Q1 		$2.56M Sell
92,397
-96,749
-51% -$2.49M 0.65% 57
2025
Q4 		$4.1M Sell
189,146
-50,274
-21% -$992K 0.95% 43
2025
Q3 		$3.62M Sell
239,420
-241,915
-50% -$2.99M 0.23% 47
2025
Q2 		$5.42M Sell
481,335
-14,462
-3% -$157K 0.36% 33
2025
Q1 		$5M Sell
495,797
-32,234
-6% -$349K 0.29% 32
2024
Q4 		$6.25M Hold
528,031
– – 0.37% 29
2024
Q3 		$6.09M Sell
528,031
-41,714
-7% -$475K 0.28% 34
2024
Q2 		$6.02M Sell
569,745
-99,302
-15% -$1.09M 0.24% 32
2024
Q1 		$7.05M Hold
669,047
– – 0.28% 34
2023
Q4 		$7.51M Buy
669,047
+70,315
+12% +$685K 0.31% 47
2023
Q3 		$6.99M Sell
598,732
-159,843
-21% -$1.81M 0.27% 44
2023
Q2 		$7.65M Buy
758,575
+135,997
+22% +$1.22M 0.27% 45
2023
Q1 		$4.59M Buy
622,578
+66,964
+12% +$551K 0.16% 57
2022
Q4 		$4.44M Buy
555,614
+50,037
+10% +$278K 0.17% 55
2022
Q3 		$1.63M Hold
505,577
– – 0.07% 83
2022
Q2 		$2.06M Buy
505,577
+181,934
+56% +$722K 0.08% 81
2022
Q1 		$1.6M Hold
323,643
– – 0.05% 91
2021
Q4 		$3.26M Buy
+323,643
New +$2.69M 0.09% 76

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Platinum Investment Management's ROIV Position: Q2 2026 in Review

Platinum Investment Management held its Roivant Sciences (ROIV) position steady in Q2 2026 at 92,397 shares worth $3.27M. The position accounts for 0.8% of the portfolio, ranked #48.

Platinum Investment Management first reported a position in ROIV in Q4 2021 and has held it in 19 quarters since. The position peaked at $7.65M in Q2 2023. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Platinum Investment Management held 92,397 shares of Roivant Sciences worth $3.27M as of Q2 2026.
  • Platinum Investment Management left its Roivant Sciences share count unchanged in Q2 2026.
  • Roivant Sciences made up 0.8% of Platinum Investment Management's portfolio in Q2 2026, its #48 holding.
  • Platinum Investment Management first reported a position in Roivant Sciences in Q4 2021 and has held it in 19 quarters since.
  • Platinum Investment Management's Roivant Sciences position peaked at $7.65M in Q2 2023.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Platinum Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.